News
Important Only
Academy Sports And Outdoors Reports First Quarter Fiscal 2025 Results
June 10 (Reuters) - Academy Sports and Outdoors Inc ASO.O:ACADEMY SPORTS + OUTDOORS REPORTS FIRST QUARTER FISCAL 2025 RESULTSSAYS REDUCED FISCAL 2025 PROJECTED CAPITAL EXPENDITURESREVISES 2025 GUIDANCE TO ACCOUNT FOR MULTIPLE TARIFF SCENARIOS WHILE MAINTAINING HIGH ENDOUTLOOK: FY ADJUSTED EPS $5.45 ...Reuters
Tue, Jun 10
OFS Credit Company Announces Financial Results For Second Fiscal Quarter 2025
June 10 (Reuters) - OFS Credit Company Inc OCCI.O:OFS CREDIT COMPANY ANNOUNCES FINANCIAL RESULTS FOR THE SECOND FISCAL QUARTER 2025OFS CREDIT COMPANY INC -Q2 NAV PER COMMON SHARE DECREASES TO $6.17 FROM $7.00OFS CREDIT COMPANY INC - Q2 NET INVESTMENT INCOME OF $5.2 MILLION, OR $0.21 PER SHAREOFS CRE...Reuters
Tue, Jun 10
'Python Huntress' takes on invasive snakes in the Everglades
By Maria Alejandra CardonaOCHOPEE, Florida, June 10 (Reuters) - Amy Siewe was a successful real estate agent -- but her life changed after she captured her first python in Florida's Everglades."I just had this fascination with snakes. So when I learned that there was a python problem here in...Reuters
Tue, Jun 10
Arcutis Enrolls First Child In INTEGUMENT-INFANT Evaluating ZORYVE Cream 0.05% In Infants With Atopic Dermatitis
June 10 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O:ARCUTIS ENROLLS FIRST CHILD IN INTEGUMENT-INFANT EVALUATING ZORYVE® (ROFLUMILAST) CREAM 0.05% IN INFANTS WITH ATOPIC DERMATITISReuters
Tue, Jun 10
Antares Therapeutics Launches With $177 Million To Develop First-In-Class Precision Medicines For Cancer And Other Serious Diseases
June 10 (Reuters) - ANTARES THERAPEUTICS LAUNCHES WITH $177 MILLION TO DEVELOP FIRST-IN-CLASS PRECISION MEDICINES FOR CANCER AND OTHER SERIOUS DISEASESReuters
Tue, Jun 10
X4 Pharmaceuticals Granted Fast Track Designation For Mavorixafor For Treatment Of Chronic Neutropenia By US FDA
June 10 (Reuters) - X4 Pharmaceuticals Inc XFOR.O:X4 PHARMACEUTICALS GRANTED FAST TRACK DESIGNATION FOR MAVORIXAFOR FOR THE TREATMENT OF CHRONIC NEUTROPENIA BY U.S. FDAX4 PHARMACEUTICALS INC - CONDUCTING PHASE 3 TRIAL FOR MAVORIXAFOR IN CNReuters
Tue, Jun 10
US wants Rwandan troops out of Congo before peace deal signed, sources say
U.S. brokering talks between Congo and RwandaDeal would facilitate billions of dollars in Western investmentConflict in eastern Congo has roots in 1994 Rwandan genocideRwanda denies backing M23 rebels and says it is acting in self-defenceQatar also hosting talks between Congo and M23By Sonia Rolley ...Reuters
Tue, Jun 10
Pennsylvania Governor Josh Shapiro On Amazon Investment Says Anticipate Creating About 10,000 Construction Jobs, 1,250 Permanent Jobs - CNBC Interview
June 10 (Reuters) - PENNSYLVANIA GOVERNOR JOSH SHAPIRO ON AMAZON INVESTMENT: ANTICIPATE CREATING ABOUT 10,000 CONSTRUCTION JOBS, 1,250 PERMANENT JOBS (NOT 12,150 PERMANENT JOBS) - CNBC INTERVIEWReuters
Tue, Jun 10
